Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis

about

MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma.Micro-RNAs in hepatitis B virus-related chronic liver diseases and hepatocellular carcinoma

P2860

Q52590673-AB5496E3-1D66-4360-B501-5EAEEA0A338A Q57491234-B6DB1BB5-C3FF-48F7-8E4E-915296BF3A00

P2860

Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis

Item

http://www.wikidata.org/entity/Q41279746

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Circulating miR-21 serves as a ...... elated with distant metastasis

@en

type

Item

label

Circulating miR-21 serves as a ...... elated with distant metastasis

@en

prefLabel

Circulating miR-21 serves as a ...... elated with distant metastasis

@en

P1476

Circulating miR-21 serves as a ...... elated with distant metastasis

@en

P2093

Lin Chen

http://www.w3.org/2001/XMLSchema#string

Xiaohui Lv

http://www.w3.org/2001/XMLSchema#string

Xin Guo

http://www.w3.org/2001/XMLSchema#string

Xing Lv

http://www.w3.org/2001/XMLSchema#string

Yong Chen

http://www.w3.org/2001/XMLSchema#string

Yueyun Ma

http://www.w3.org/2001/XMLSchema#string

P2860

microRNA Therapeutics in Cancer - An Emerging Concept

The crosstalk between microRNAs and the Wnt/β-catenin signaling pathway in cancer

Advance in microRNA as a potential biomarker for early detection of pancreatic cancer

Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma.

Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer

Hemolysis-free plasma miR-214 as novel biomarker of gastric cancer and is correlated with distant metastasis

Significance of serum microRNA-21 in diagnosis of hepatocellular carcinoma (HCC): clinical analyses of patients and an HCC rat model.

Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.

A microRNA biomarker of hepatocellular carcinoma recurrence following liver transplantation accounting for within-patient heterogeneity.

Serum miR-96 is a promising biomarker for hepatocellular carcinoma in patients with chronic hepatitis B virus infection.

P304

44050-44058

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.17211

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28477010

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

5546461

http://www.w3.org/2001/XMLSchema#string

Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis

about

P2860

P2860

Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932